Amgen CEO says U.S. Medicare out-of-pocket cap will improve access

Covid live: UK records 217 deaths and 41,299 new infections; US to begin vaccinating children aged 5-11 Call for federal bushfire bunker approach before ‘more lives are lost’ By Deena Beasley
© Reuters/STEPHEN LAM FILE PHOTO: Amgen Chairman and CEO Robert Bradway speaks during an interview on the sidelines of the 38th Annual JP Morgan Healthcare Conference in San Francisco (Reuters) – A proposed cap on out-of-pocket drug costs for Medicare recipients would improve patient access, but allowing the U.S. government health plan for seniors to negotiate prices could limit innovation, Amgen Inc Chief Executive Robert Bradway said in …

Read the source article at msn.com
2021-11-03 03:00:00